The Vital Triad of ADC Design: Target, Indication & Payload

Time: 9:30 am
day: Day One


  • Reviewing how the selection of an ADC target requires consideration of the potential clinical indications and the mechanistic properties of available linker payloads
  • Assessing how the availability of novel differentiated linker-payloads provides an opportunity to calibrate potential clinical success against validated clinical benchmarks
  • Presenting case study examples to demonstrate integration of target selection, clinical indication options and payload MoA